US Oncology- Central Drug — Fort Worth, Texas

US Oncology- Central Drug is a clinical research site located in Fort Worth, Texas, United States 76177.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

US Oncology- Central Drug has participated in 1 clinical trials.

Therapeutic areas: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Millennium Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Worth

Browse all research sites in Texas · View every site in Fort Worth

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology- Central Drug?

US Oncology- Central Drug has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology- Central Drug conducted?

US Oncology- Central Drug has 1 clinical trials on record. Their work covers Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL).

Is US Oncology- Central Drug accredited by Crixeo Clinical Trials?

US Oncology- Central Drug has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology- Central Drug?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.